BlackRock Japan
ABMD

BlackRock Japan’s Abiomed Inc ABMD Stock Holding History

BlackRock Japan’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-265
Closed -$34K – 1394
2016
Q3 		$34K Sell
265
-21
-7% -$2.52K ﹤0.01% 1034
2016
Q2 		$31K Buy
286
+69
+32% +$6.87K ﹤0.01% 1079
2016
Q1 		$21K Hold
217
– – ﹤0.01% 1181
2015
Q4 		$20K Buy
+217
New +$18.4K ﹤0.01% 1162

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BlackRock Japan's ABMD Position: Q4 2016 in Review

BlackRock Japan sold out of Abiomed Inc (ABMD) in Q4 2016, closing a stake of 265 shares — an estimated $34K sold.

BlackRock Japan first reported a position in ABMD in Q4 2015 and held it in 4 quarters. The position peaked at $34K in Q3 2016. 297 funds tracked by Wall St. Rank hold ABMD as of Q4 2016.

  • BlackRock Japan reported no remaining Abiomed Inc position as of Q4 2016 after selling out during the quarter.
  • BlackRock Japan sold 265 Abiomed Inc shares in Q4 2016, an estimated $34K.
  • BlackRock Japan first reported a position in Abiomed Inc in Q4 2015 and held it in 4 quarters.
  • BlackRock Japan's Abiomed Inc position peaked at $34K in Q3 2016.
  • 297 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.